Company intelligence / Profile preview
Natrusolate
- Ownership
- Private
- Development stage
- Other
Overview
Natrusolate is a biotechnology company focused on the discovery and development of high-potency natural compounds for the treatment of metabolic and inflammatory diseases. The company utilizes a proprietary extraction and purification platform to isolate specific bioactive molecules from botanical sources, aiming to bridge the gap between traditional herbal medicine and modern pharmacology. Their lead research efforts are directed toward identifying natural insulin sensitizers and anti-inflammatory agents that can be developed as standardized therapeutic interventions. Natrusolate's business model encompasses both the development of a proprietary pipeline and the supply of high-purity active ingredients to the pharmaceutical and nutraceutical industries.
- Therapeutic areas
- EndocrinologyImmunologyMetabolic Disorders
- Modalities
- Small moleculeNatural products
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Natrusolate.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Natrusolate.